Heart Failure Biomarkers

The Prognostic Role of Regular NT-proBNP Measurement A er a Rapid-Up Titration Programme of Guideline-Directed Medical Therapy in Heart Failure: Essential or Superfluous?

by Prateek Chopra | May 25, 2026 | Cardiology Conferences | ESC-HF 2026 N-terminal pro-B-type natriuretic peptide (NT-proBNP) is an important prognostic biomarker in heart failure (HF). The 2023 ESC HF Guidelines recommend rapid up-titration (RT) of guideline-directed medical therapy (GDMT) following an index HF hospitalization; however, the prognostic significance of NT-proBNP changes after a rapid titration programme (RTP) remains uncertain. […]

The Prognostic Role of Regular NT-proBNP Measurement A er a Rapid-Up Titration Programme of Guideline-Directed Medical Therapy in Heart Failure: Essential or Superfluous? Read Post »

Leave a Comment / ESC-HF Day 2 / / / , , , ,

Left Ventricular Ejection on Fraction, Ventricular Remodelling and Outcomes After Sacubitril – Valsartan in a Real-Life Cohort

by Prateek Chopra | May 17, 2026 | Cardiology Conferences | ESC-HF 2026 Sacubitril–valsartan (SV) has demonstrated prognostic benefits in patients with heart failure with reduced ejection fraction (HFrEF), although its long-term impact in real-world clinical practice remains unclear. This study assessed long-term outcomes associated with SV use in a real-world HFrEF cohort. The findings were presented at Heart Failure 2026,

Left Ventricular Ejection on Fraction, Ventricular Remodelling and Outcomes After Sacubitril – Valsartan in a Real-Life Cohort Read Post »

Leave a Comment / ESC-HF Day 1 / / / , , , ,

The Prognostic Value of NT-proBNP Variability Measured During Rou ne Follow-Up in Outpatients with Heart Failure with Reduced Ejection Fraction

by Prateek Chopra | May 19, 2026 | Cardiology Conferences | ESC-HF 2026 N-terminal pro–B-type natriuretic peptide (NT-proBNP) is an established biomarker for risk stratification in Heart Failure with reduced ejection fraction (HFrEF). However, the prognostic significance of serial variability in NT-proBNP levels during routine follow-up in clinically stable patients remains unclear. This study aimed to determine whether fluctuations in NT-proBNP

The Prognostic Value of NT-proBNP Variability Measured During Rou ne Follow-Up in Outpatients with Heart Failure with Reduced Ejection Fraction Read Post »

Leave a Comment / ESC-HF Day 1 / / / , , , ,
Scroll to Top